A damaging trial failure in December wiped 70% off the share price of BioAge Labs, a US biopharma developing therapeutic ...
The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...
Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...
If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...
DRIPBaR Direct' is designed to provide The DRIPBaR's clients with convenient access to personalized health and wellness solutions from the comfort of their homes. Through the VSDHOne platform, clients ...
The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.
The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.
Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...
Hosted on MSN13h
Skin Envy explains Semaglutide and TirzepatideAn Air Force F-35 fighter jet crashed on Tuesday during a training mission in central Alaska. Officials say the crash ...
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback